TY  - GEN
AU  - Jacquin,Jean-Philippe
AU  - Chargari,Cyrus
AU  - Thorin,Julie
AU  - Mille,Dominique
AU  - Mélis,Adrien
AU  - Orfeuvre,Hubert
AU  - Clavreul,Guillaume
AU  - Chaigneau,Loic
AU  - Nourissat,Alice
AU  - Dumanoir,Chantal
AU  - Savary,Jacqueline
AU  - Merrouche,Yacine
AU  - Magné,Nicolas
TI  - Phase II trial of pegylated liposomal doxorubicin in combination with gemcitabine in metastatic breast cancer patients
SN  - 1537-453X
PY  - 2012///0227
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - administration & dosage
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Deoxycytidine
KW  - Disease-Free Survival
KW  - Doxorubicin
KW  - Drug Administration Schedule
KW  - Female
KW  - Hand-Foot Syndrome
KW  - etiology
KW  - Humans
KW  - Injections, Intravenous
KW  - Middle Aged
KW  - Neutropenia
KW  - chemically induced
KW  - Polyethylene Glycols
KW  - Stomatitis
KW  - Thrombocytopenia
KW  - Treatment Outcome
KW  - Gemcitabine
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study
UR  - https://doi.org/10.1097/COC.0b013e3182005783
ER  -